Sign up to save your podcasts
Or
Share Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Consolidative Immunotherapy in Unresectable Stage III NSCLC: Case Discussion
CME credits: 1.00
Valid until: 25-06-2025
Claim your CME credit at https://reachmd.com/programs/cme/optimizing-consolidative-immunotherapy-in-unresectable-stage-iii-nsclc-case-discussion/24392/
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 25-06-2025
Claim your CME credit at https://reachmd.com/programs/cme/optimizing-consolidative-immunotherapy-in-unresectable-stage-iii-nsclc-case-discussion/24392/
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.